BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1568789)

  • 1. Hypoxanthine-guanine phosphoribosyl-transferase in childhood leukemia: relation with immunophenotype, in vitro drug resistance and clinical prognosis.
    Pieters R; Huismans DR; Loonen AH; Peters GJ; Hählen K; van der Does-van den Berg A; van Wering ER; Veerman AJ
    Int J Cancer; 1992 May; 51(2):213-7. PubMed ID: 1568789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine deaminase and purine nucleoside phosphorylase in childhood lymphoblastic leukemia: relation with differentiation stage, in vitro drug resistance and clinical prognosis.
    Pieters R; Huismans DR; Loonen AH; Peters GJ; Hählen K; van der Does-van den Berg A; van Wering ER; Veerman AJ
    Leukemia; 1992 May; 6(5):375-80. PubMed ID: 1593902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of 5'-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia.
    Pieters R; Huismans DR; Loonen AH; Peters GJ; Hählen K; van der Does-van den Berg A; van Wering ER; Veerman AJ
    Leuk Res; 1992 Sep; 16(9):873-80. PubMed ID: 1405718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia.
    Pieters R; Kaspers GJ; van Wering ER; Huismans DR; Loonen AH; Hählen K; Veerman AJ
    Leukemia; 1993 Mar; 7(3):392-7. PubMed ID: 8445945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited intra-individual variability in hypoxanthine-Guanine phosphoribosyl transferase, thiopurine S-methyl transferase, and xanthine oxidase activity in inflammatory bowel disease patients during 6-thioguanine therapy.
    van Asseldonk DP; de Boer NK; Smid K; Mulder CJ; van Bodegraven AA; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):284-90. PubMed ID: 20544508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of mercaptopurine (6MP) metabolites and 6MP metabolic key-enzymes in childhood acute lymphoblastic leukemia.
    Wojtuszkiewicz A; Barcelos A; Dubbelman B; De Abreu R; Brouwer C; Bökkerink JP; de Haas V; de Groot-Kruseman H; Jansen G; Kaspers GL; Cloos J; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):422-33. PubMed ID: 24940700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of in vitro drug resistance testing in childhood acute lymphoblastic leukemia: the state of the art.
    Pieters R; Kaspers GJ; Klumper E; Veerman AJ
    Med Pediatr Oncol; 1994; 22(5):299-308. PubMed ID: 8127253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and cell biological features related to cellular drug resistance of childhood acute lymphoblastic leukemia cells.
    Kaspers GJ; Pieters R; Van Zantwijk CH; Van Wering ER; Veerman AJ
    Leuk Lymphoma; 1995 Nov; 19(5-6):407-16. PubMed ID: 8590840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups.
    Ramakers-van Woerden NL; Pieters R; Hoelzer D; Slater RM; den Boer ML; Loonen AH; Harbott J; Janka-Schaub GE; Ludwig WD; Ossenkoppele GJ; van Wering ER; Veerman AJ;
    Med Pediatr Oncol; 2002 Jun; 38(6):379-86. PubMed ID: 11984797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversion in expression of hypoxanthine-guanine phosphoribosyltransferase in 6-thioguanine resistant neuroblastoma: evidence for reduced enzyme levels associated with unaltered catalytic activity.
    Skaper SD; Spector EB; Seegmiller JE
    J Cell Physiol; 1977 Aug; 92(2):275-83. PubMed ID: 18484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative assay of mutation induction at the hypoxanthine-guanine phosphoribosyl transferase locus in Chinese hamster ovary cells (CHO/HGPRT system): development and definition of the system.
    O'Neill JP; Brimer PA; Machanoff R; Hirsch GP; Hsie AW
    Mutat Res; 1977 Oct; 45(1):91-101. PubMed ID: 917038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the concentrative nucleoside transporter 3 and equilibrative nucleoside transporter 2 in the resistance of T-lymphoblastic cell lines to thiopurines.
    Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
    Biochem Biophys Res Commun; 2006 Apr; 343(1):208-15. PubMed ID: 16530731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red blood cell hypoxanthine phosphoribosyltransferase activity measured using 6-mercaptopurine as a substrate: a population study in children with acute lymphoblastic leukaemia.
    Lennard L; Hale JP; Lilleyman JS
    Br J Clin Pharmacol; 1993 Oct; 36(4):277-84. PubMed ID: 12959304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired transport as a mechanism of resistance to thiopurines in human T-lymphoblastic leukemia cells.
    Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1039-44. PubMed ID: 17065061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants.
    Pieters R; den Boer ML; Durian M; Janka G; Schmiegelow K; Kaspers GJ; van Wering ER; Veerman AJ
    Leukemia; 1998 Sep; 12(9):1344-8. PubMed ID: 9737681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-Thioguanine-induced growth arrest in 6-mercaptopurine-resistant human leukemia cells.
    Morgan CJ; Chawdry RN; Smith AR; Siravo-Sagraves G; Trewyn RW
    Cancer Res; 1994 Oct; 54(20):5387-93. PubMed ID: 7923170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The isolation and preliminary characterisation of 6-thioguanine-resistant mutants of human diploid fibroblasts.
    Cox R; Masson WK
    Mutat Res; 1976 Jul; 36(1):93-104. PubMed ID: 950955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of mutations by chemical agents at the hypoxanthine-guanine phosphoribosyl transferase locus in human epithelial teratoma cells.
    Huberman E; McKeown CK; Jones CA; Hoffman DR; Murao SI
    Mutat Res; 1984 Apr; 130(2):127-37. PubMed ID: 6717466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological characterization of hypoxanthine-guanine phosphoribosyl transferase mutants of mouse L cells: evidence for mutations at different loci in the HGPRT gene.
    Wahl GM; Hughes SH; Capecchi MR
    J Cell Physiol; 1975 Apr; 85(2 Pt 1):307-20. PubMed ID: 47331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allopurinol enhances the activity of hypoxanthine-guanine phosphoribosyltransferase in inflammatory bowel disease patients during low-dose thiopurine therapy: preliminary data of an ongoing series.
    Seinen ML; de Boer NK; Smid K; van Asseldonk DP; Bouma G; van Bodegraven AA; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1085-90. PubMed ID: 22132961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.